Literature DB >> 23237702

OPTN/SRTR 2011 Annual Data Report: international data.

B L Kasiske1, M A Skeans, T R Leighton, V Ghimire, S N Leppke, A K Israni.   

Abstract

For the first time, OPTN/SRTR has undertaken to publish global transplant rates as part of its Annual Data Report. Understanding why rates vary from country to country may lead to a better understanding of how to improve access to transplant everywhere. Availability of information varies substantially from country to country, and how complete and accurate the data are is difficult to ascertain. For Canada, Malaysia, and the United Kingdom, data were supplied at SRTR request from well-known registries. For many other countries, SRTR was unable to obtain information, and data from the World Health Organization's Global Observatory on Donation and Transplantation were used. Transplant counts and rates vary substantially around the world, likely due to 1) differences in rates of end-organ diseases, 2) economic differences in the ability to provide transplants or other end-organ disease treatment, 3) cultural differences that might support or hinder organ donation and transplant, and 4) reporting differences. © Copyright 2012 The American Society of Transplantation and the American Society of Transplant Surgeons.

Entities:  

Mesh:

Year:  2013        PMID: 23237702     DOI: 10.1111/ajt.12026

Source DB:  PubMed          Journal:  Am J Transplant        ISSN: 1600-6135            Impact factor:   8.086


  5 in total

Review 1.  What's new in clinical solid organ transplantation by 2013.

Authors:  Maurizio Salvadori; Elisabetta Bertoni
Journal:  World J Transplant       Date:  2014-12-24

2.  The allo- and viral-specific immunosuppressive effect of belatacept, but not tacrolimus, attenuates with progressive T cell maturation.

Authors:  H Xu; S D Perez; J Cheeseman; A K Mehta; A D Kirk
Journal:  Am J Transplant       Date:  2014-02       Impact factor: 8.086

Review 3.  Human Leukocyte Antigen Sensitization in Solid Organ Transplantation: A Primer on Terminology, Testing, and Clinical Significance for the Apheresis Practitioner.

Authors:  Sarah Abbes; Ara Metjian; Alice Gray; Tereza Martinu; Laurie Snyder; Dong-Feng Chen; Matthew Ellis; Gowthami M Arepally; Oluwatoyosi Onwuemene
Journal:  Ther Apher Dial       Date:  2017-09-07       Impact factor: 1.762

4.  Metabolomic Profiling in Individuals with a Failing Kidney Allograft.

Authors:  Roberto Bassi; Monika A Niewczas; Luigi Biancone; Stefania Bussolino; Sai Merugumala; Sara Tezza; Francesca D'Addio; Moufida Ben Nasr; Alessandro Valderrama-Vasquez; Vera Usuelli; Valentina De Zan; Basset El Essawy; Massimo Venturini; Antonio Secchi; Francesco De Cobelli; Alexander Lin; Anil Chandraker; Paolo Fiorina
Journal:  PLoS One       Date:  2017-01-04       Impact factor: 3.240

5.  Levels of anti-CMV antibodies are modulated by the frequency and intensity of virus reactivations in kidney transplant patients.

Authors:  María Iglesias-Escudero; Marco Antonio Moro-García; Raquel Marcos-Fernández; Alejandra García-Torre; Marta Elena Álvarez-Argüelles; María Luisa Suárez-Fernández; Pablo Martínez-Camblor; Minerva Rodríguez; Rebeca Alonso-Arias
Journal:  PLoS One       Date:  2018-04-11       Impact factor: 3.240

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.